Emclaire Financial Corp Reports Quarterly Earnings

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Emclaire Financial Corp Reports Quarterly Earnings

EMLENTON, Pa., Oct. 21, 2016 (GLOBE NEWSWIRE) -- Emclaire Financial Corp (NASDAQ: EMCF ), the parent holding company of The Farmers National Bank of Emlenton, reported consolidated net income available to common stockholders of $1.1 million, or $0.49 per common share for the three months ended September 30, 2016 compared to $1.5 million, or $0.70 per common share for the same period in 2015.  Net income available to common shareholders for the nine-month period ended September 30, 2016 was $2.8 million, or $1.29 per diluted common share compared to $3.2 million, or $1.63 per diluted common share for the same period in 2015. 

The decline in earnings for the quarter and year-to-date periods primarily related to an increase in the provision for loan losses and a decrease in noninterest income.  During the third quarter of 2015, the Corporation recorded an unusual recovery of loan losses of $102,000 related to an improvement in credit quality compared to a provision for loan losses of $168,000 recorded during the third quarter of 2016.  Also during the third quarter of 2015, the Corporation sold certain securities to accommodate loan production and generated $533,000 of net gains, compared to no gains realized during the third quarter of 2016.

William C. Marsh, Chairman, President and Chief Executive Officer of the Corporation and the Bank, noted, “We are pleased with our results thus far in 2016, including strong balance sheet growth, the successful acquisition and integration of United American Savings Bank (UASB) in April 2016 and the grand opening of our full-service office in Aspinwall, Pennsylvania in August 2016.  In the upcoming quarters, we will be focusing on identifying additional business opportunities in the Pittsburgh market, continuing to expand our loan portfolio, managing operating expenses, and effectively deploying capital to continue profitable growth of our franchise.”

OPERATING RESULTS OVERVIEW

Net income available to common stockholders decreased $437,000, or 29.2%, to $1.1 million, or $0.49 per common share for the three months ended September 30, 2016 compared to $1.5 million, or $0.70 per common share, for the same period in 2015.  The decrease in net income primarily resulted from increases in the provision for loan losses and noninterest expense of $270,000 and $567,000, respectively, and a decrease in noninterest income of $367,000, partially offset by an increase in net interest income of $579,000 and decreases in the provision for income taxes and preferred stock dividends of $163,000 and $25,000, respectively.

Noninterest income decreased $367,000, or 26.6%, to $1.0 million for the quarter ended September 30, 2016 from $1.4 million for the same period in 2015.  This decrease primarily resulted from a $533,000 decrease in net gains on the sale of securities.  During the three months ended September 30, 2015, the Corporation sold certain securities to accommodate loan production and generated $533,000 of net gains.  During the three months ended September 30, 2016, the Corporation did not realize any securities gains, but did recognize $121,000 in gains on loans sold to the Federal Home Loan Bank of Pittsburgh (FHLB).  Absent these security and loan sale gains, the Corporation’s noninterest income would have increased $45,000, or 5.3%, to $891,000 for the quarter ended September 30, 2016 from $846,000 for the same period in 2015.

The provision for loan losses increased $270,000 to $168,000 for the quarter ended September 30, 2016 from a $102,000 recovery for the same period in 2015.  The provision for loan losses recorded in the third quarter of 2016 reflects a level of expense that is typically experienced by the Corporation. The $102,000 recovery recognized during the third quarter of 2015 resulted from a general improvement in economic factors and historical loss ratios of the overall loan portfolio and the improvement of two large commercial loan relationships which previously had substantial specific reserves allocated. 

Noninterest expense increased $567,000, or 14.4%, to $4.5 million for the quarter ended September 30, 2016 from $3.9 million for the same period in 2015.  The increase primarily related to increases in compensation and benefits, premises and equipment expense and other noninterest expense of $256,000, $86,000 and $192,000, respectively, which were primarily driven by the Bank’s two new branch banking offices resulting from the acquisition of UASB and the opening of the new Aspinwall branch. 

Net interest income increased $579,000, or 13.1%, to $5.0 million for the quarter ended September 30, 2016 from $4.4 million for the same period in 2015.  The increase in net interest income resulted from an increase in interest income of $981,000, or 19.2%, as the Corporation experienced a $103.0 million increase in the average balance of loans between the quarterly periods.  Partially offsetting the increase in interest income, interest expense increased $402,000, or 58.5%, as the Corporation’s average balance of interest-bearing deposits and borrowed funds increased $83.1 million and $16.7 million, respectively, between the quarterly periods.  The increases in the Corporation’s interest-earning assets and interest-bearing liabilities includes the impact of the aforementioned acquisition of UASB.

CONSOLIDATED YEAR-TO-DATE OPERATING RESULTS OVERVIEW

Net income available to common stockholders decreased $364,000, or 11.5%, to $2.8 million, or $1.29 per diluted common share, for the nine months ended September 30, 2016, compared to $3.2 million, or $1.63 per diluted common share, for the same period in the prior year.  The decrease in net income primarily resulted from increases in the provision for loan losses and noninterest expense of $201,000 and $1.1 million, respectively, and a decrease in noninterest income of $272,000, partially offset by an increase in net interest income of $1.1 million and a decrease in preferred stock dividends of $75,000 as a result of the redemption of the SBLF preferred stock in September 2015.

Noninterest income decreased $272,000, or 9.1%, to $2.7 million for the nine months ended September 30, 2016 from $3.0 million for the same period in 2015.  This decrease primarily resulted from a $484,000 decrease in net gains on the sale of securities.  During the nine months ended September 30, 2015, the Corporation recorded securities gains totaling $567,000 related to the aforementioned security sales to accommodate loan growth compared to securities gains of $83,000 realized during the nine months ended September 30, 2016.  Additionally, the Corporation recognized $121,000 in gains on loans sold to the FHLB in the current period.  Absent these security and loan sale gains, the Corporation’s noninterest income would have increased $91,000, or 3.7%, to $2.5 million for the nine months ended September 30, 2016 from $2.4 million for the same period in 2015.

The provision for loan losses increased $201,000, or 74.7%, to $470,000 for the nine months ended September 30, 2016 from $269,000 for the same period in 2015.  The provision for loan losses recorded for the nine months ended September 30, 2016 reflects a level of expense that is typically experienced by the Corporation. The lower level of provision for loan losses recorded during the same period in 2015 resulted from a $102,000 recovery of loan losses recorded in the third quarter of 2015 following a general improvement in economic factors and historical loss ratios of the overall loan portfolio and the improvement of two large commercial loan relationships during the third quarter which previously had substantial specific reserves allocated. 

Noninterest expense increased $1.1 million, or 9.0%, to $13.0 million for the nine months ended September 30, 2016 from $11.9 million for the same period in 2015.  The increase primarily related to acquisition related costs of $401,000 and increases in compensation and benefits, premises and equipment expense and other noninterest expense of $362,000, $140,000 and $148,000, respectively.     

Net interest income increased $1.1 million, or 8.4%, to $14.4 million for the nine months ended September 30, 2016 from $13.3 million for the same period in 2015.  The increase in net interest income resulted from an increase in interest income of $1.9 million, or 12.5%, as the Corporation experienced an $80.4 million increase in the average balance of loans.  Partially offsetting the increase in interest income, interest expense increased $811,000, or 38.1%, as the Corporation’s average balance of interest-bearing deposits and borrowed funds increased $42.7 million and $17.5 million, respectively.  The increases in the Corporation’s interest-earning assets and interest-bearing liabilities includes the impact of the aforementioned acquisition of UASB. 

CONSOLIDATED BALANCE SHEET & ASSET QUALITY OVERVIEW

Total assets increased $93.1 million, or 15.5%, to $693.7 million at September 30, 2016 from $600.6 million at December 31, 2015.  Asset growth was driven by increases in loans receivable and cash and equivalents of $78.4 million and $15.3 million, respectively, partially offset by a decrease in investment securities of $10.5 million.  Liabilities increased $90.7 million, or 16.6%, to $638.5 million at September 30, 2016 from $547.8 million at December 31, 2015 due to an increase in customer deposits of $102.7 million, partially offset by a decrease in borrowed funds of $12.0 million.  Loans and deposits acquired from UASB totaled $66.1 million and $72.7 million, respectively, at the time of acquisition in April 2016. 

Total nonperforming assets remained low at $3.3 million, or 0.51% of total assets at September 30, 2016 compared to $3.2 million, or 0.54% of total assets at December 31, 2015.

Stockholders’ equity increased $2.4 million, or 4.5%, to $55.2 million at September 30, 2016 from $52.8 million at December 31, 2015.  The Corporation remains well capitalized and is positioned for continued growth with total stockholders’ equity at 8.0% of total assets.  Tangible book value per common share was $20.64 at September 30, 2016, compared to $22.67 at December 31, 2015.

Emclaire Financial Corp is the parent company of The Farmers National Bank of Emlenton, an independent, nationally chartered, FDIC-insured community bank headquartered in Emlenton, Pennsylvania, operating 17 full service offices in Venango, Allegheny, Butler, Clarion, Clearfield, Crawford, Elk, Jefferson and Mercer counties, Pennsylvania.  The Corporation’s common stock is quoted on and traded through the NASDAQ Capital Market under the symbol “EMCF”.  For more information, visit the Corporation’s website at “ www.emclairefinancial.com ”.

This news release may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements may contain words such as “believe”, “expect”, “anticipate”, “estimate”, “should”, “may”, “can”, “will”, “outlook”, “project”, “appears” or similar expressions.  Such forward-looking statements are subject to risk and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors. Such factors include, but are not limited to, changes in interest rates which could affect net interest margins and net interest income, the possibility that increased demand or prices for the Corporation's financial services and products may not occur, changing economic and competitive conditions, technological and regulatory developments, and other risks and uncertainties, including those detailed in the Corporation's filings with the Securities and Exchange Commission.  The Corporation does not undertake, and specifically disclaims any obligation to update any forward-looking statements to reflect occurrences or unanticipated events or circumstances after the date of such statements.

EMCLAIRE FINANCIAL CORP  
Consolidated Financial Highlights  
(Unaudited - Dollar amounts in thousands, except share data)  
                   
CONSOLIDATED OPERATING RESULTS DATA: Three month period   Nine month period  
    ended September 30,   ended September 30,  
      2016       2015       2016       2015    
                   
Interest income $ 6,094     $ 5,113     $ 17,319     $ 15,398    
Interest expense   1,089       687       2,938       2,127    
Net interest income   5,005       4,426       14,381       13,271    
Provision for (recovery of) loan losses   168       (102 )     470       269    
Noninterest income   1,012       1,379       2,734       3,006    
Noninterest expense   4,494       3,927       12,975       11,902    
Income before provision for income taxes   1,355       1,980       3,670       4,106    
Provision for income taxes   297       460       880       877    
Net income   1,058       1,520       2,790       3,229    
Accumulated preferred stock dividends   -       25       -       75    
Net income available to common stockholders $ 1,058     $ 1,495     $ 2,790     $ 3,154    
                   
Basic earnings per common share $ 0.49     $ 0.70     $ 1.30     $ 1.64    
Diluted earnings per common share $ 0.49     $ 0.70     $ 1.29     $ 1.63    
Dividends per common share $ 0.26     $ 0.24     $ 0.78     $ 0.72    
                   
Return on average assets (1)   0.60 %     1.02 %     0.57 %     0.73 %  
Return on average equity (1)   7.64 %     10.50 %     6.87 %     8.24 %  
Return on average common equity (1)   7.64 %     11.31 %     6.87 %     8.89 %  
Yield on average interest-earning assets   3.82 %     3.77 %     3.86 %     3.83 %  
Cost of average interest-bearing liabilities   0.85 %     0.67 %     0.83 %     0.69 %  
Cost of funds   0.68 %     0.52 %     0.66 %     0.54 %  
Net interest margin   3.15 %     3.28 %     3.22 %     3.32 %  
Efficiency ratio   71.92 %     71.23 %     73.26 %     72.39 %  
____________________                
(1) Returns are annualized for the three and nine month periods ended September 30, 2016 and 2015.      
                   
CONSOLIDATED BALANCE SHEET DATA:     As of   As of      
        9/30/2016   12/31/2015      
                   
Total assets     $ 693,672     $ 600,595        
Cash and equivalents       26,804       11,546        
Securities       102,463       112,981        
Loans, net       508,241       429,891        
Deposits       592,600       489,887        
Borrowed funds       37,250       49,250        
Stockholders' equity       55,216       52,839        
                   
Book value per common share     $ 25.73     $ 24.64        
Tangible book value per common share     $ 20.64     $ 22.67        
                   
Net loans to deposits       85.76 %     87.75 %      
Allowance for loan losses to total loans       1.07 %     1.20 %      
Nonperforming assets to total assets       0.51 %     0.54 %      
Earning assets to total assets       93.57 %     93.52 %      
Stockholders' equity to total assets       7.96 %     8.80 %      
Shares of common stock outstanding       2,146,308       2,144,808        
                   

CONTACT: William C. Marsh Chairman, President and Chief Executive Officer                                                                Phone: (844) 800-2193 Email:  investor.relations@farmersnb.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading